and J. Moon, "Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia," Expert Review of Cardiovascular Therapy, vol. 8, no. 8, pp. 1079-1090, 2010.Gotto AM; Moon J.Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.Ex- pert Rev Cardiovasc...
Primary Hyperlipidemia and Mixed DyslipidemiaDrug TrialsShow entriesDrugDrug NamePhaseStatusCount DB01076 Atorvastatin 3 Completed 1 DB09303 Evolocumab 3 Completed 1 Showing 1 to 2 of 2 entries ‹ 1 › Stay up-to-date with the latest from DrugBank! Subscribe Downloads Data Library Academic...
Micronized fenofibrate may be considered an effective first-line therapy for patients with primary hyperlipidemia, particularly those with type IIb mixed dyslipidemia or type 2 diabetes. 展开 关键词: Keyword Highlighting Highlight selected keywords in the article text ...
and several trials of its possible lipid-lowering effects have been conducted. This meta-analysis assesses the effectiveness and safety of RYR preparations on lipid modification in primary hyperlipidemia. We included randomized controlled trials
Davidson, Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravas- tatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a phase IV, prospective, US, multicenter, randomized, double- blind, superiority trial, Clin. Ther. 36 (8) (2014) 1211e1...
leaves on hyperlipidemia in rats fed a high-fat diet: Induction of fatty acid oxidation, inhibition of lipogenesis, and suppression of oxidative stress. Biosci. Biotechnol. Biochem. 2010, 74, 2385–2395. [CrossRef] [PubMed] 3. Pothinuch, P.; Tongchitpakdee, S. Melatonin contents in ...